Sign up
Research trends

What otorhinolaryngology is researching now

The topics gaining the most ground, ranked by the PubDaily Trend Score: new research, stronger evidence, new trials and new guidelines. 291 topics in 22 specialties, updated 18 Oct 2026.

Monthly reportThe fastest-rising topics in medicine: October 2026Read →
12 topics · otorhinolaryngology

Biologics for nasal polyps

Rising
+28%new papersScore 56
20212026

Dupilumab and other biologics for chronic rhinosinusitis with nasal polyps.

522 papers / yr18 new trials1 new guideline
See all papers →

Vestibular migraine

Rising
+16%new papersScore 56
20212026

Diagnosis and treatment of vestibular migraine.

177 papers / yr13 new trials
See all papers →

Gene therapy for hearing loss

Steady
+9%new papersScore 52
20212026

Gene therapy for genetic deafness, such as OTOF mutations.

138 papers / yr6 new trials1 new guideline
See all papers →

Hearing loss and dementia

Steady
+16%new papersScore 48
20212026

Hearing loss, hearing aids and cognitive decline.

608 papers / yr16 new trials5 new guidelines
See all papers →

Hypoglossal nerve stimulation

Steady
+3%new papersScore 43
20212026

An implanted stimulator for obstructive sleep apnoea.

Key point: In France, hypoglossal nerve stimulation is indicated for non-obese moderate-to-severe OSAHS patients with CPAP or MAD failure or contraindications after mandatory DISE.

114 papers / yr10 new trials1 new guideline
See all papers →

Tinnitus

Steady
-1%new papersScore 43
20212026

Tinnitus mechanisms and treatments, including neuromodulation.

1,116 papers / yr90 new trials5 new guidelines
See all papers →

See all 12 otorhinolaryngology topics

Every rising topic, with the papers behind it. Free for doctors.

How the Trend Score works

Four signals

Growth in new papers (35%), growth in randomised trials, meta-analyses and systematic reviews (25%), new clinical trials registered (20%), and new guidelines and consensus statements (20%), each over the last 12 months against the 12 before.

A score out of 100

Each signal is ranked against every topic we follow, so a score of 90 means the topic is ahead of about 90% of them. Rising fast: 80 and above. Rising: 55 to 79. Emerging: fewer than 100 papers the year before, too few to rank.

What it does not tell you

More research on a topic is not evidence that a treatment works. Open a topic to read the papers and guidelines themselves. Counts come from PubMed and ClinicalTrials.gov.